v1
Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
Identifier:nobleid.org/w1/20260515/FE4F44EF
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/FE4F44EF)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims